1.    Research Framework

1.1. Research Objective

1.2. Product Overview

1.3. Market Segmentation

2.    Research Methodology

2.1. Qualitative Research

2.1.1.   Primary & Secondary Research

2.2. Quantitative Research

2.3. Market Breakdown & Data Triangulation

2.3.1.   Primary & Secondary Research End-use Industry

2.3.2.   Secondary Research

2.3.3.   Primary Research

2.4. Breakdown of Primary Research Respondents, By Region

2.5. Assumption & Limitation

3.    Executive Summary

4.    Global Drug Screening Market Insights

4.1. Industry Value Chain Analysis

4.2. DROC Analysis

4.2.1.   Growth Drivers

4.2.2.   Restraints

4.2.3.   Opportunities

4.2.4.   Challenges

4.3. Porter’s Five Forces Analysis

4.3.1.   Bargaining End-use Industry of Suppliers

4.3.2.   Bargaining End-use Industry of Buyers

4.3.3.   Threat of New Entrants

4.3.4.   Threat of Substitutes

4.3.5.   Intensity of Rivalry

4.4. Recent Development/ Technological Advancement

4.5. Regulatory Insights

5.    Global Drug Screening Market Overview

5.1. Market Size & Forecast by Value, 2017-2027

5.1.1.   By Value (USD Billion)        

5.2. Market Share & Forecast

5.2.1.   By Products & Services

5.2.1.1.       Equipment

5.2.1.1.1. Immunoassay Analyzers

5.2.1.1.2. Chromatography Instruments

5.2.1.1.3. Breath Analyzers

5.2.1.1.4. Others

5.2.1.2.       Rapid Testing Devices

5.2.1.2.1. Urine Testing Devices

5.2.1.2.2. Oral Fluid Testing Devices

5.2.1.2.3. Others

5.2.1.3.       Consumables

5.2.1.3.1. Assay Kits

5.2.1.4.       Laboratory Services

5.2.1.5.       Accessories

5.2.1.5.1. Calibrators and Controls

5.2.1.5.2. Sample Collection Cups

5.2.1.6.       Others

5.2.2.   By Sample Type

5.2.2.1 Oral Fluid or Saliva

5.2.2.2 Breath

5.2.2.3 Hair

5.2.2.4 Urine

5.2.2.5 Others

5.2.3.  By End-user

5.2.3.1. Workplace & Schools

5.2.3.2. Laboratories

5.2.3.3. Criminal Justice

5.2.3.4. Hospitals

5.2.3.5. Drug testing laboratories

5.2.3.6. Personal users

5.2.3.7. Others

           5.2.4. By Region

               5.2.4.1. North America

5.2.4.2. Europe

               5.2.4.3. Asia-Pacific

5.2.4.4. Latin America

               5.2.4.5. Middle East and Africa

6.    North Drug Screening Market

6.1. Market Size & Forecast by Value, 2017-2027

6.1.1.   By Value (USD Billion)

6.2. Market Share & Forecast

6.2.1.   By Products & Services

6.2.2.   By Sample Type

6.2.3.   By End-User

6.2.4.   By Country

6.2.4.1.     U.S.

6.2.4.2.     Canada

7.    Europe Drug Screening Market 

7.1. Market Size & Forecast by Value, 2017-2027

7.1.1.   By Value (USD Billion)

7.2. Market Share & Forecast

7.2.1.   By Products & Services

7.2.2.   By Sample Type

7.2.3.   By End-User

7.2.4.   By Country

7.2.4.1.       France

7.2.4.2.       Germany

7.2.4.3.       Italy

7.2.4.4.       Spain

7.2.4.5.       U.K.

7.2.4.6.       The Netherlands

7.2.4.7.       Belgium

7.2.4.8.       Russia

7.2.4.9.       NORDIC Countries

7.2.4.10.    Rest of Europe

8.    The Asia-Pacific (APAC) Drug Screening Market 

8.1. Market Size & Forecast by Value, 2017-2027

8.1.1.   By Value (USD Billion)

8.2. Market Share & Forecast

8.2.1.   By Products & Services

8.2.2.   By Sample Type

8.2.3.   By End-User

8.2.4.   By Country

8.2.4.1.     Japan

8.2.4.2.     China

8.2.4.3.     India

8.2.4.4.     South Korea

8.2.4.5.     Australia and New Zealand

8.2.4.6.     Southeast Asia Countries

8.2.4.7.     Rest of APAC

9.    Latin America Drug Screening Market

9.1. Market Size & Forecast by Value, 2017-2027

9.1.1.   By Value (USD Billion)

9.2. Market Share & Forecast

9.2.1.   By Products & Services

9.2.2.   By Sample Type

9.2.3.   By End-User

9.2.4.   By Country

9.2.4.1.     Brazil

9.2.4.2.     Argentina

9.2.4.3.     Mexico

9.2.4.4.     Colombia

9.2.4.5.     Rest of Latin America

10.The Middle East & Africa (MEA) Drug Screening Market

10.1.     Market Size & Forecast by Value, 2017-2027

10.1.1.    By Value (USD Billion)

10.2.     Market Share & Forecast

10.2.1.    By Products & Services

10.2.2.    By Sample Type

10.2.3.    By End-User

10.2.4.    By Country

10.2.4.1.    South Africa

10.2.4.2.    Saudi Arabia

10.2.4.3.    U.A.E.

10.2.4.4.    Qatar

10.2.4.5.    Kuwait

10.2.4.6.    Iran

10.2.4.7.    Turkey

10.2.4.8.    Rest of MEA

11.Competitive Landscape

11.1.     List of Key Players and their Offerings

11.2.     Company Market Share Analysis, 2020

11.3.     Competitive Benchmarking, By Operating Parameters

11.4.     Competitive Benchmarking, By Product Offerings

11.5.     Strategic Developments

12.Impact of Covid-19 across Global Drug Screening Market

13.Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *

 

13.1.     LabCorp

13.2.     Quest Diagnostics

13.3.     Abbott Rapid Diagnostics

13.4.     OraSure Technologies

13.5.     Alfa Scientific Designs

13.6.     Thermo Fisher Scientific

13.7.     Dragerwerk AG

13.8.     Lifeloc Technologies

13.9.     MPD Inc.

13.10.  Omega Laboratories

13.11.  Premier Biotech Inc.

13.12.  Psychemedics Corporation

13.13.  Roche AG

13.14.  Shimadzu Corporation

13.15.  Siemens Healthcare

13.16.  BioMerieux SA

13.17.  Synergy Health plc.

13.18.  CareHealth America Corporation

13.19.  Biomedical Diagnostics

13.20.  Agilent Technologies

13.21.  Other Prominent Players.

14.Key Strategic Recommendations

 

*Financial details of unlisted companies will be available as per data availability in the final deliverable

**The segmentation and the companies are subjected to modifications based on the in-depth secondary for the final deliverable

 

List of figures

Fig: Global Drug Screening Segmentation

 

Fig: Global Drug Screening Market Value Chain Analysis

 

Fig: Company Market Share Analysis, 2020

 

Fig: Global Drug Screening Market Size, By Value (USD Billion), 2017-2027

 

Fig: Global Drug Screening Market Share (%), By Products & Services, By Value, 2017-2027

 

Fig: Global Drug Screening Market Share (%), By Sample Type, By Value, 2017-2027

 

Fig: Global Drug Screening Market Share (%), By End-User, By Value, 2017-2027

 

Fig: Global Drug Screening Market Share (%), By Country, By Value, 2017-2027

 

Fig: North America Drug Screening Market Size, By Value (USD Billion), 2017-2027

 

Fig: North America Drug Screening Market Share (%), By Products & Services, By Value, 2017-2027

 

Fig: North America Drug Screening Market Share (%), By Sample Type, By Value, 2017-2027

 

Fig: North America Drug Screening Market Share (%), By End-User, By Value, 2017-2027

 

Fig: North America Drug Screening Market Share (%), By Country, By Value, 2017-2027

 

Fig: Europe Drug Screening Market Size, By Value (USD Billion), 2017-2027

 

Fig: Europe Drug Screening Market Share (%), By Products & Services, By Value, 2017-2027

 

Fig: Europe Drug Screening Market Share (%), By Sample Type, By Value, 2017-2027

 

Fig: Europe Drug Screening Market Share (%), By End-User, By Value, 2017-2027

 

Fig: Europe Drug Screening Market Share (%), By Country, By Value, 2017-2027

 

Fig: Asia-Pacific Drug Screening Market Size, By Value (USD Billion), 2017-2027

 

Fig: Asia-Pacific Drug Screening Market Share (%), By Products & Services, By Value, 2017-2027

 

Fig: Asia-Pacific Drug Screening Market Share (%), By Sample Type, By Value, 2017-2027

 

Fig: Asia-Pacific Drug Screening Market Share (%), By End-User, By Value, 2017-2027

 

Fig: Asia-Pacific Drug Screening Market Share (%), By Country, By Value, 2017-2027

 

Fig: Latin America Drug Screening Market Size, By Value (USD Billion), 2017-2027

 

Fig: Latin America Drug Screening Market Share (%), By Products & Services, By Value, 2017-2027

 

Fig: Latin America Drug Screening Market Share (%), By Sample Type, By Value, 2017-2027

 

Fig: Latin America Drug Screening Market Share (%), By End-User, By Value, 2017-2027

 

Fig: Latin America Drug Screening Market Share (%), By Country, By Value, 2017-2027

 

Fig: Middle East & Africa Drug Screening Market Size, By Value (USD Billion), 2017-2027

 

Fig: Middle East & Africa Drug Screening Market Share (%), By Products & Services, By Value, 2017-2027

 

Fig: Middle East & Africa Drug Screening Market Share (%), By Sample Type, By Value, 2017-2027

 

Fig: Middle East & Africa Drug Screening Market Share (%), By End-User, By Value, 2017-2027

 

Fig: Middle East & Africa Drug Screening Market Share (%), By Country, By Value, 2017-2027

 

 

 

 

 

List of Tables

 

Table: Global Drug Screening Market Size, By Products & Services, By Value, 2017-2027

 

Table: Global Drug Screening Market Size, By Sample Type, By Value, 2017-2027

 

Table: Global Drug Screening Market Size, By End-User, By Value, 2017-2027

 

Table: Global Drug Screening Market Size, By Region, By Value, 2017-2027

 

Table: North America Drug Screening Market Size, By Products & Services, By Value, 2017-2027

 

Table: North America Drug Screening Market Size, By Sample Type, By Value, 2017-2027

 

Table: North America Drug Screening Market Size, By End-User, By Value, 2017-2027

 

Table: North America Drug Screening Market Size, By Country, By Value, 2017-2027

 

Table: Europe Drug Screening Market Size, By Products & Services, By Value, 2017-2027

 

Table: Europe Drug Screening Market Size, By Sample Type, By Value, 2017-2027

 

Table: Europe Drug Screening Market Size, By End-User, By Value, 2017-2027

 

Table: Europe Drug Screening Market Size, By Country, By Value, 2017-2027

 

Table: Asia-Pacific Drug Screening Market Size, By Products & Services, By Value, 2017-2027

 

Table: Asia-Pacific Drug Screening Market Size, By Sample Type, By Value, 2017-2027

Table: Asia-Pacific Drug Screening Market Size, By End-User, By Value, 2017-2027

Table: Asia-Pacific Drug Screening Market Size, By Country, By Value, 2017-2027

Table: Latin America Drug Screening Market Size, By Products & Services, By Value, 2017-2027

Table: Latin America Drug Screening Market Size, By Sample Type, By Value, 2017-2027

Table: Latin America Drug Screening Market Size, By End-User, By Value, 2017-2027

Table: Latin America Drug Screening Market Size, By Country, By Value, 2017-2027

Table: Middle East & Africa Drug Screening Market Size, By Products & Services, By Value, 2017-2027

Table: Middle East & Africa Drug Screening Market Size, By Sample Type, By Value, 2017-2027

Table: Middle East & Africa Drug Screening Market Size, By End-User, By Value, 2017-2027

Table: Middle East & Africa Drug Screening Market Size, By Country, By Value, 2017-2027

 

Table: LabCorp Financial Analysis

Table: LabCorp Business Overview

Table: Quest Diagnostics Financial Analysis

Table:  Quest Diagnostics Business Overview

Table: Abbott Rapid Diagnostics Financial Analysis

Table: Abbott Rapid Diagnostics Business Overview

Table: OraSure Technologies Financial Analysis

Table: OraSure Technologies Business Overview

Table:  Alfa Scientific Designs Financial Analysis

Table:  Alfa Scientific Designs Business Overview

Table: Thermo Fisher Scientific Financial Analysis

Table: Thermo Fisher Scientific Business Overview

Table: Dragerwerk AG Financial Analysis

Table: Dragerwerk AG Business Overview

Table: Lifeloc Technologies Financial Analysis

Table: Lifeloc Technologies Business Overview

Table: MPD Inc.Financial Analysis

Table: MPD Inc.Business Overview

Table: Omega LaboratoriesFinancial Analysis

Table:  Omega LaboratoriesBusiness Overview

Table:  Premier Biotech Inc. Financial Analysis

Table:  Premier Biotech Inc. Business Overview

Table:  Psychemedics Corporation Financial Analysis

Table:  Psychemedics Corporation Business Overview